Dexmedetomidine vs. Ketorolac/ Midazolam for Retinal Surgery

PHASE4CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

January 1, 2016

Primary Completion Date

November 29, 2016

Study Completion Date

November 30, 2016

Conditions
Retinal Surgery
Interventions
DRUG

Dexmedetomidine group (D)

Patients received 1ug/kg dexmedetomidine in 50 ml saline over 10 min i.v 30 min before induction then 0.4 ug/kg/h dexmedetomidine (4ug/ml) and normal saline 0.1 ml/kg till end of surgery, using two syringe pumps one for dexmedetomidine and the other for saline

DRUG

Ketorolac-Midazolam group (KM)

Patients received 0.5mg/kg ketolac in 50 ml saline over 10 min before induction and 25ug/kg midazolam in 50 ml saline over 10 min i.v 30 min before induction then 50ug/kg/h of ketolac and 40ug/kg/h midazolam till end of surgery in two separate syringe pumps.

DRUG

Control group (Normal Saline) (C)

Patients received normal saline in two sets

All Listed Sponsors
lead

Mansoura University

OTHER

NCT03143244 - Dexmedetomidine vs. Ketorolac/ Midazolam for Retinal Surgery | Biotech Hunter | Biotech Hunter